首页>投融资

PharmEnable

PreA轮

PharmEnable Ltd is a Cambridge-based drug discovery company and a spin-out from the University of Cambridge, focused to develop and design the next generation of highly complex and specific drug candidate molecules using advanced medicinal chemistry and AI-enabled approaches.In July 2023, PharmEnable closed a total of $7.5 million in pre-Series A funding.In May 2023, PharmEnable closed a Pre-Series A investment round of $7.5M.In June 2020, the company raised EURO 1.8 million through seed financing

https://pharmenable.com/

470180

基本信息

公司全称

PharmEnable
类型

小分子药物开发商
产业领域

研发制造服务、药品研发/制造
公司人数

15人以下
地址

Compass House,Vision Park Histon CAMBRIDGE CAMBRIDGESHIRE CB23; GB;
联系电话
邮箱

info@pharmenable.com
成立时间

2016-01-01

投融资

2023-05-22

PreA轮

750万美元

O2h Ventures

University of Cambridge Seed Funds

University of Cambridge Enterprise Fund VIII

Martlet Capital

Heyford Trust

Wren Capital

Arrowfield Capital

MP Healthcare Venture Management
2023-05-22

PreA轮

750万美元

University of Cambridge Seed Funds

Wren Capital

Arrowfield Capital

Heyford Trust

MP Healthcare Venture Management

Martlet Capital

University of Cambridge Enterprise Fund VIII

O2h Ventures
2020-06-30

种子轮

180万英镑

University of Cambridge Seed Funds
2020-06-30

种子轮

180万英镑

University of Cambridge Seed Funds
加载更多

PharmEnable

基本信息

投融资

相关投融资企业